Anavex Life Sciences Reports Fiscal Third Quarter
Post# of 1460
(Total Views: 455)
Posted On: 08/09/2018 2:52:55 PM
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results,
Fletch
August 9, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – August 9, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease,…
NEW YORK (AP) _ Anavex Life Sciences Corp. (AVXL) on Thursday reported a loss of $2.8 million in its fiscal third quarter.
On a per-share basis, the New York-based company said it had a loss of 6 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The company's shares closed at $2.90. A year ago, they were trading at $3.74.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVXL at https://www.zacks.com/ap/AVXL
More on this at:
https://finance.yahoo.com/news/anavex-life-sc...00231.html
Fletch
August 9, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – August 9, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease,…
NEW YORK (AP) _ Anavex Life Sciences Corp. (AVXL) on Thursday reported a loss of $2.8 million in its fiscal third quarter.
On a per-share basis, the New York-based company said it had a loss of 6 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The company's shares closed at $2.90. A year ago, they were trading at $3.74.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVXL at https://www.zacks.com/ap/AVXL
https://finance.yahoo.com/news/anavex-life-sc...00231.html
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼